Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2014-12-25 Director's Dealing
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
103年12月24日內部人設質解質
Director's Dealing Classification · 100% confidence The document is a short tabular report showing a pledge of shares by a company director (黃國杰) with details on the number of shares pledged and the pledgee. The document length is only 324 characters, indicating it is a brief notification rather than a full report. The content corresponds to a director's dealing in shares, specifically a pledge of shares by a director. Therefore, the appropriate classification is Director's Dealing (DIRS).
2014-12-25 Chinese
103年11月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial statements, earnings data, meeting materials, or regulatory announcements. The document is not a report or announcement of a report but a detailed disclosure of insider share transactions and holdings. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is sufficient and the content matches the definition of DIRS filings.
2014-12-11 Chinese
103年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It lists their share counts, pledged shares, and related percentages. The content focuses on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. This type of disclosure aligns with reporting insider share transactions or holdings. Given the nature of the data and the focus on insider holdings, the document fits best under the category of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is 2611 characters, which is consistent with a detailed insider shareholding report rather than a full financial report or announcement. Therefore, the classification is DIRS with high confidence.
2014-12-11 Chinese
103年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. There is no indication of a full report, management discussion, or regulatory certification. The document appears to be a regulatory announcement or compliance disclosure rather than a full financial report or detailed filing. Given the brevity and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-12-10 Chinese
103年11月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summarized revenue report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes and explanatory notes. It is very short (786 characters) and contains no detailed financial statements or comprehensive analysis. It appears to be a brief financial summary or factsheet rather than a full financial report or earnings release. There is no indication of it being an announcement of a report publication or regulatory filing. Given the concise nature and content, the best fitting category is Fund Information / Factsheet (FS).
2014-12-10 Chinese
103年第3季財務報告書 — 201401_3164_AI1.pdf
Regulatory Filings
2014-11-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.